|
PHC3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.588000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.821800E-01 |
| Normal-vs-Stage2 |
5.816000E-01 |
| Normal-vs-Stage3 |
4.060800E-01 |
| Normal-vs-Stage4 |
7.915600E-01 |
| Stage1-vs-Stage2 |
3.043400E-01 |
| Stage1-vs-Stage3 |
7.450000E-01 |
| Stage1-vs-Stage4 |
6.853600E-01 |
| Stage2-vs-Stage3 |
3.443800E-01 |
| Stage2-vs-Stage4 |
9.801800E-01 |
| Stage3-vs-Stage4 |
6.153200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.196200E-01 |
| Normal-vs-AfricanAmerican |
9.840200E-01 |
| Normal-vs-Asian |
9.198300E-03 |
| Caucasian-vs-AfricanAmerican |
9.582800E-01 |
| Caucasian-vs-Asian |
2.033000E-01 |
| AfricanAmerican-vs-Asian |
1.844630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.869400E-01 |
| Normal-vs-Female |
1.756210E-01 |
| Male-vs-Female |
8.005700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.182000E-01 |
| Normal-vs-Extreme_Weight |
8.154000E-02 |
| Normal-vs-Obese |
3.814400E-01 |
| Normal-vs-Extreme_Obese |
6.060400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.672200E-01 |
| Normal_Weight-vs-Obese |
3.431200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.905000E-01 |
| Extreme_Weight-vs-Obese |
2.701600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.864200E-01 |
| Obese-vs-Extreme_Obese |
3.729800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.057600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.149400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.525800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.157830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.585600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.784200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.120800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.582300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.454400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.029800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.112800E-01 |
| Normal-VS-Type2 PRCC |
5.977500E-02 |
| Normal-VS-KIRP CIMP |
5.742800E-01 |
| Normal-VS-Unclassified PRCC |
3.142800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.419890E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.574200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.610000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.317000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.750300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.931800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.162500E-03 |
| Normal-vs-N1 |
9.480200E-01 |
| Normal-vs-N2 |
7.111000E-01 |
| N0-vs-N1 |
9.648300E-02 |
| N0-vs-N2 |
5.657200E-01 |
| N1-vs-N2 |
7.191000E-01 |
|
|
